Clinical Trial Update: Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether early erythropoietin reduces transfusion needs in pediatric patients with anemia, including neoplasms and chemotherapy-induced a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chemotherapy-induced Anemia
• Neoplasms

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Blau Farmaceutica S.A. | Conditions: Anemia, Neoplasms | Phase 3 | Status: UNKNOWN